369 related articles for article (PubMed ID: 31699735)
1. CRISTAL: protocol for a cluster randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested study.
Sidhu VS; Graves SE; Buchbinder R; Naylor JM; Pratt NL; de Steiger RS; Chong BH; Ackerman IN; Adie S; Harris A; Hansen A; Cripps M; Lorimer M; Webb S; Clavisi O; Griffith EC; Anandan D; O'Donohue G; Kelly TL; Harris IA
BMJ Open; 2019 Nov; 9(11):e031657. PubMed ID: 31699735
[TBL] [Abstract][Full Text] [Related]
2. CRISTAL (a cluster-randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested study): statistical analysis plan.
Sidhu VS; Kelly TL; Pratt N; Graves S; Buchbinder R; Naylor J; de Steiger R; Ackerman I; Adie S; Lorimer M; Bastiras D; Cashman K; Harris I
Trials; 2021 Aug; 22(1):564. PubMed ID: 34429127
[TBL] [Abstract][Full Text] [Related]
3. Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial.
; Sidhu VS; Kelly TL; Pratt N; Graves SE; Buchbinder R; Adie S; Cashman K; Ackerman I; Bastiras D; Brighton R; Burns AWR; Chong BH; Clavisi O; Cripps M; Dekkers M; de Steiger R; Dixon M; Ellis A; Griffith EC; Hale D; Hansen A; Harris A; Hau R; Horsley M; James D; Khorshid O; Kuo L; Lewis P; Lieu D; Lorimer M; MacDessi S; McCombe P; McDougall C; Mulford J; Naylor JM; Page RS; Radovanovic J; Solomon M; Sorial R; Summersell P; Tran P; Walter WL; Webb S; Wilson C; Wysocki D; Harris IA
JAMA; 2022 Aug; 328(8):719-727. PubMed ID: 35997730
[TBL] [Abstract][Full Text] [Related]
4. Aspirin or enoxaparin for VTE prophylaxis after primary partial, total or revision hip or knee arthroplasty: A secondary analysis from the CRISTAL cluster randomized trial.
CRISTAL Study Group
PLoS One; 2024; 19(4):e0298152. PubMed ID: 38626226
[TBL] [Abstract][Full Text] [Related]
5. Safety and effectiveness of aspirin and enoxaparin for venous thromboembolism prophylaxis after total hip and knee arthroplasty: a systematic review.
Nadi S; Vreugdenburg TD; Atukorale Y; Ma N; Maddern G; Rovers M
ANZ J Surg; 2019 Oct; 89(10):1204-1210. PubMed ID: 30989803
[TBL] [Abstract][Full Text] [Related]
6. Effect of Aspirin vs Enoxaparin on 90-Day Mortality in Patients Undergoing Hip or Knee Arthroplasty: A Secondary Analysis of the CRISTAL Cluster Randomized Trial.
; Sidhu VS; Kelly TL; Pratt N; Graves SE; Buchbinder R; Adie S; Cashman K; Ackerman IN; Bastiras D; Brighton R; Burns AWR; Chong BH; Clavisi O; Cripps M; Dekkers M; de Steiger R; Dixon M; Ellis A; Griffith EC; Hale D; Hansen A; Harris A; Hau R; Horsley M; James D; Khorshid O; Kuo L; Lewis PL; Lieu D; Lorimer M; MacDessi SJ; McCombe P; McDougall C; Mulford J; Naylor JM; Page RS; Radovanovic J; Solomon M; Sorial R; Summersell P; Tran P; Walter WL; Webb S; Wilson C; Wysocki D; Harris IA
JAMA Netw Open; 2023 Jun; 6(6):e2317838. PubMed ID: 37294566
[TBL] [Abstract][Full Text] [Related]
7. Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis.
Farey JE; An VVG; Sidhu V; Karunaratne S; Harris IA
Orthop Traumatol Surg Res; 2021 Feb; 107(1):102606. PubMed ID: 32631716
[TBL] [Abstract][Full Text] [Related]
8. Is Enoxaparin Associated With a Higher Risk of Persistent Wound Drainage Than Aspirin? A Secondary Analysis of Data From the CRISTAL Randomized Trial.
Sidhu VS; Naylor JM; Adie S; Lieu D; Walker R; Horsley M; Kim RG; Harris IA
Clin Orthop Relat Res; 2023 Jul; 481(7):1351-1359. PubMed ID: 36649465
[TBL] [Abstract][Full Text] [Related]
9. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
[TBL] [Abstract][Full Text] [Related]
10. No Increased Risk of Venous Thromboembolism in High-Risk Patients Continuing Their Dose of 75 mg Aspirin Compared to Healthier Patients Given Low-Molecular-Weight Heparin.
Hovik O; Amlie EJ; Jenssen KK
J Arthroplasty; 2021 Oct; 36(10):3589-3592. PubMed ID: 34176693
[TBL] [Abstract][Full Text] [Related]
11. Dual mobility versus conventional total hip arthroplasty in femoral neck fractures (DISTINCT): protocol for a registry-nested, open-label, cluster-randomised crossover trial.
Farey JE; Hooper T; Alland T; Naylor JM; Kelly TL; Lorimer M; Lewin AM; Rogers M; Law CK; Close J; Graves SE; de Steiger RS; Lewis PL; Adie S; Harris IA
BMJ Open; 2022 Sep; 12(9):e064478. PubMed ID: 36130765
[TBL] [Abstract][Full Text] [Related]
12. Systematic review of aspirin for thromboprophylaxis in modern elective total hip and knee arthroplasty.
Wilson DG; Poole WE; Chauhan SK; Rogers BA
Bone Joint J; 2016 Aug; 98-B(8):1056-61. PubMed ID: 27482017
[TBL] [Abstract][Full Text] [Related]
13. Staged venous thromboemolic events prophylaxis with low-molecular-weight heparin followed by aspirin is safe and effective after arthroplasty.
Asopa V; Cobain W; Martin D; Keene G; Bauze A
ANZ J Surg; 2015 Sep; 85(9):652-7. PubMed ID: 25997601
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of low-molecular-weight heparin compared with aspirin for prophylaxis against venous thromboembolism after total joint arthroplasty.
Schousboe JT; Brown GA
J Bone Joint Surg Am; 2013 Jul; 95(14):1256-64. PubMed ID: 23864173
[TBL] [Abstract][Full Text] [Related]
15. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of enoxaparin versus aspirin in the prevention of venous thromboembolism after total hip or knee arthroplasty: an analysis from the CRISTAL cluster-randomized trial.
CRISTAL Economic Analysis Study Group
Bone Joint J; 2024 Jun; 106-B(6):589-595. PubMed ID: 38821513
[TBL] [Abstract][Full Text] [Related]
17. Incidence of venous thromboembolism after total hip, total knee and hip fracture surgery at Waitemata District Health Board following a peer-reviewed audit.
Millar JS; Lawes CM; Farrington B; Andrew P; Misur P; Merriman E; Walker M
N Z Med J; 2020 Mar; 133(1511):52-60. PubMed ID: 32161421
[TBL] [Abstract][Full Text] [Related]
18. PREVENTion of CLots in Orthopaedic Trauma (PREVENT CLOT): a randomised pragmatic trial protocol comparing aspirin versus low-molecular-weight heparin for blood clot prevention in orthopaedic trauma patients.
O'Toole RV; Stein DM; Frey KP; O'Hara NN; Scharfstein DO; Slobogean GP; Taylor TJ; Haac BE; Carlini AR; Manson TT; Sudini K; Mullins CD; Wegener ST; Firoozabadi R; Haut ER; Bosse MJ; Seymour RB; Holden MB; Gitajn IL; Goldhaber SZ; Eastman AL; Jurkovich GJ; Vallier HA; Gary JL; Kleweno CP; Cuschieri J; Marvel D; Castillo RC;
BMJ Open; 2021 Mar; 11(3):e041845. PubMed ID: 33762229
[TBL] [Abstract][Full Text] [Related]
19. Mobile Compression Reduces Bleeding-related Readmissions and Wound Complications After THA and TKA.
Arsoy D; Giori NJ; Woolson ST
Clin Orthop Relat Res; 2018 Feb; 476(2):381-387. PubMed ID: 29529673
[TBL] [Abstract][Full Text] [Related]
20. Comparative effectiveness of venous thromboembolism prophylaxis options for the patient undergoing total hip and knee replacement: a network meta-analysis.
Kapoor A; Ellis A; Shaffer N; Gurwitz J; Chandramohan A; Saulino J; Ishak A; Okubanjo T; Michota F; Hylek E; Trikalinos TA
J Thromb Haemost; 2017 Feb; 15(2):284-294. PubMed ID: 28102615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
